The benefit of adjuvant radiotherapy (RT) for patients with early-stage oral cavity squamous cell carcinoma (OSCC) or p16-negative oropharyngeal squamous cell carcinoma (OPSCC) with a solitary ipsilateral lymph node metastasis remains unclear.
